Health
Bharat Biotech Gets Rights To Make 100 Crores Doses Of Nasal Adenovirus Vaccine
Hyderabad based Bharat Biotech on Wednesday announced its manufacturing up to 100 crores doses of a single dose intranasal adenovirus vaccine for COVID-19. The company along with the US-based biotech firm Precision Virologics has collaborated with the Washington University School of Medicine in St....
Latest News
Oxford University Starts COVID-19 Vaccine Trials, First Volunteer Injected
The Logical Indian Crew